Clinical Trial Update: DUR-928 in Patients With Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for DUR-928 in patients with alcoholic hepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• DUR-928

Snippet

Sponsor: Craig James McClain | Conditions: Alcoholic Hepatitis | Phase 2 | Status: COMPLETED